Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Hematologic Disorder, Bleeding Disorder, Connective Tissue Disorder.
Sponsors: American Thrombosis and Hemostasis Network.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania has 2 clinical trials on record, with 1 currently active. Their work covers Hematologic Disorder, Bleeding Disorder, Connective Tissue Disorder.
Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.